News ConTIPI starts rollout of pelvic organ prolapse device in US A non-invasive device that could help millions of women in the US with a condition known as pelvic organ prolapse (POP) has launched in the US.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.